Puebla-Miranda M, Vásquez-Ramírez M, González-Ibarra M, Torres-López IH

Language: Spanish
References: 12
Page: 246-250
PDF size: 212.97 Kb.

ABSTRACT

Sporotrichosis is a subcutaneous mycosis frequent in Mexico, of subacute or chronic evolution, acquired by traumatic inoculation or by inhalation of conidia of the species of the Sporothrix schenckii complex. It is characterized by the presence of nodular lesions in skin and subcutaneous tissue. It is considered an occupational disease and its form of entry is through traumatism. Activities associated with the development of sporotrichosis include ornamental gardening, rose cultivation and other activities involving fungus inoculation through the skin. We report the case of 23-years old man, from the state of Guerrero, resident of the city of Los Cabos, Baja California, with a gardening occupational activity, with a six months history of evolution, which after to a traumatism well identified presented a dermatosis located in the region of the right hand dorsum, constituted by an indurated, erythematous, squamous plaque, with definite limits, followed by ulcerated nodules of linear distribution in forearm and right arm. He received empirical treatment with Terbinafine with partial improvement. The diagnosis of cutaneous lymphangitic sporotrichosis was confirmed with mycological culture, in which Sporothrix schenckii sensu stricto was identified. The patient was treated with potassium iodide for three months, obtaining clinical and mycological cure. Conclusion: We reported a case of lymphangitic sporotrichosis acquired in a non-endemic area, but with occupational risk factor to present the disease.

REFERENCES

1. Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S. Global epidemiology of esporotrichosis. Med Mycol 2015; 53(1): 3-14.

2. Ramírez-Soto MC, Aguilar-Ancori EG, Tirado-Sánchez A, Bonifaz A. Ecological determinants of sporotrichosis etiological agents. J Fungi 2018; 4(3): 95.

3. Bonifaz A, Toriello C, Araiza J, Ramírez-Soto MC, Tirado-Sánchez. Sporotrichin skin test for the diagnosis of sporotrichosis. J Fungi 2018; 4(2): 55.

4. Mayorga J, Tarango-Martínez V y BarbaRubio J. Esporotricosis 100 años después (1898-1998). Dermatología Rev Mex 1999; 43: 22-9.

5. Padilla-Desgarennes MC, Zuloeta-Espinosa de los Monteros EI, Novales_Santa Coloma J. Esporotricosis linfangítica. Presentación de un caso. Rev Cent Dermatol Pascua 2002; 11(3): 131-4.

6. Conceição-Silva F, Morgado FN. Immunopathogenesis of human sporotrichosis: what we already know. J Fungi 2018; 4(3): 89.

7. Arenas R, Sánchez-Cardenas CD, Ramirez-Hobak L, Ruíz Arriaga LF, Vega Memije ME. Sporotrichosis: from KOH to molecular biology. J Fungi 2018; 4(2): 62.

8. García-Carnero LC, Lozaya-Pérez NE, González-Hernández SE, Martínez-Alvarez JA, Inmunity and treatment of sporotrichosis. J Fungi 2018; 4(3): 100.

9. Gaviria-Giraldo CM, Cardona-Castro N. Esporotricosis y cromoblastomicosis: revisión de la literatura. Rev CES Med. 2017; 31(1): 77-91.

10. Orofino-Costa R, Macedo PM, Rodrigues AM, Bernardes-Engemann AR. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. An Bras Dermatol 2017; 92(5): 606-20.

11. Mahajan VK. Sporotrichosis: an overview and therapeutic options. Dermatol Res Pract 2014; 2014: 272-376.

12. Rojas OC, Bonifaz A, Campos C, Treviño-Rangel RJ, González-Álvarez R, González GM. Molecular identification, antifungal susceptibility, and geographic origin of clinical strains of Sporothrix schenckii complex in Mexico. J Fungi 2018; 4(3): 86.